المؤلفون: Tobias Nordström, Andrea Discacciati, Martin Bergman, Mark Clements, Markus Aly, Magnus Annerstedt, Axel Glaessgen, Stefan Carlsson, Fredrik Jäderling, Martin Eklund, Henrik Grönberg, Carin Cavalli-Björkman, Astrid Björklund, Britt-Marie Hune, Shuang Hao, Mats Walldén, Ola Steinberg, Karl Andersson, Fredrik Wimmercranz, Edward Meurling, Axel Gleassgen, Nada Majeed, Rihab Awadelkarim, Ing-Marie Fyhr, Dag Sandström, Linda Waage, Otabek Imamov, Rafael Lantz, Andreas Thorstensson, Carl Stiernstedt, Dushaid Wande, Gunnar Trygg, Harald Söderbäck, Jerzy Michajlowski, Lars Leykamm, Nils-Erik Svedberg, Tommy Bergman, Raimundas Sabockis, Sirvan Akrawi

المصدر: The Lancet Oncology. 22:1240-1249

مصطلحات موضوعية: Image-Guided Biopsy, Male, medicine.medical_specialty, Prostate biopsy, Risk Assessment, Random Allocation, Prostate cancer, Prostate, Internal medicine, Biopsy, Biomarkers, Tumor, medicine, Humans, Prospective Studies, Prospective cohort study, Early Detection of Cancer, Aged, Sweden, Intention-to-treat analysis, medicine.diagnostic_test, business.industry, Prostatic Neoplasms, Cancer, Middle Aged, Prostate-Specific Antigen, medicine.disease, Magnetic Resonance Imaging, Intention to Treat Analysis, Prostate cancer screening, medicine.anatomical_structure, ROC Curve, Oncology, Neoplasm Grading, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1d5c61d968ec8aa8d5dd5b9acb709b
https://doi.org/10.1016/s1470-2045(21)00348-x